Related Experiment Videos
Syndecan-2 is essential for angiogenic sprouting during zebrafish development.
Eleanor Chen1, Spencer Hermanson, Stephen C Ekker
1Arnold and Mabel Beckman Center for Transposon Research, Department of Genetics, Cell Biology, and Development, University of Minnesota, Minneapolis, MN 55455, USA.
Blood
|November 1, 2003
Summary
Syndecan-2 is crucial for blood vessel formation (angiogenesis) in zebrafish embryos. This cell-surface proteoglycan interacts with VEGF, suggesting its potential in developing new therapies for angiogenesis-related conditions.
Area of Science:
- Developmental Biology
- Molecular Biology
- Genetics
Background:
- Vascular development is a complex process involving intricate signaling pathways.
- Angiogenic sprouting is critical for forming new blood vessels during embryogenesis.
- Identifying novel proteins involved in vascular development is essential for understanding related diseases and developing therapies.
Purpose of the Study:
- To identify novel proteins essential for vascular development using a zebrafish model.
- To investigate the role of syndecan-2 in angiogenic sprouting.
- To explore the interaction between syndecan-2 and vascular endothelial growth factor (VEGF) in vivo.
Main Methods:
- Morpholino-based gene-targeting screen in zebrafish (Danio rerio).
- Analysis of syndecan-2 expression patterns in zebrafish and mouse embryos.
- Functional studies using gain-of-function and loss-of-function approaches.
- Assessment of human syndecan-2's ability to restore angiogenic sprouting.
Main Results:
- Syndecan-2, a cell-surface heparan sulfate proteoglycan, was identified as essential for angiogenic sprouting.
- Zebrafish and mouse syndecan-2 exhibit conserved expression patterns around major trunk vessels.
- Human syndecan-2 successfully restored angiogenic sprouting in syndecan-2 morphants.
- A truncated syndecan-2 form caused angiogenesis defects, highlighting the importance of its cytoplasmic tail.
- Syndecan-2 and VEGF demonstrated in vivo genetic interaction; syndecan-2 modulates VEGF signaling.
Conclusions:
- Syndecan-2 is a novel and essential regulator of angiogenesis during embryonic development.
- The conserved cytoplasmic tail of syndecan-2 is critical for its vascular function.
- Syndecan-2 plays a significant role in VEGF-mediated signaling, suggesting a therapeutic target.
- Syndecan-2 represents a potential candidate for developing novel angiogenesis-based therapies.